What this means
This trial aims to check whether a receptor in blood vessels works in older women. It is still recruiting, so no results have been shared yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–70
- Where
- 1 site, including Missouri
The science
- Registered title
- Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
- Trial ID
- NCT07674680 ↗
- Phase
- EARLY PHASE 1
- Study type
- interventional
- Conditions
- Women, Aging, Menopause
- What is tested
- Placebo, Gemtesa
- Sponsor
- University of Missouri-Columbia
- Ages
- 18 Years to 70 Years
- Dates
- First posted Jun 29, 2026 · updated Sep 10, 2026
Registry summary
To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.
Sites (1)
- University of Missouri, Columbia, Missouri, United States